EHA HIGHLIGHTS 2024 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSION: CARTITUDE-2 COHORT D
OR
Chair
Dr. Donna Reece
Panelists
Dr. Darrell White
Dr. Maria Victoria Mateos Manteca
This program has been made possible through unrestricted support from Sanofi.
Studies/trials discussed:
- Ciltacel with or without lenalidomide maintenance in newly diagnosed multiple myeloma with suboptimal response to front line autologous stem cll transplant, CARRTITUDE-2 cohort D.
